Refine
Has Fulltext
- yes (49)
Is part of the Bibliography
- yes (49)
Document Type
- Journal article (49)
Language
- English (49) (remove)
Keywords
- COVID-19 (5)
- blood-brain barrier (4)
- acute respiratory distress syndrome (3)
- breast cancer (3)
- patient blood management (3)
- SARS-CoV-2 (2)
- blood gas analysis (2)
- clinical trial (2)
- critical care (2)
- critically ill (2)
- cytokines (2)
- exosomes (2)
- inflammation (2)
- iron deficiency (2)
- meta-analysis (2)
- microRNA (2)
- perioperative care (2)
- postoperative nausea and vomiting (2)
- stroke (2)
- (cardiac) surgery (1)
- ARDS (1)
- ARDS (acute respiratory distress syndrome) (1)
- Apple Watch 7 (1)
- Bland–Altman (1)
- Blood–brain barrier (1)
- COVID 19 (1)
- CT (1)
- CX3CL1 (1)
- CXCL13 (1)
- CXCR4-targeting (1)
- ClearSight\(^®\) (1)
- Coronavirus Disease 2019 (1)
- Covid-19 (1)
- Fisher Z-score transformation (1)
- Fitbit Sense (1)
- Garmin Fenix 6 Pro (1)
- Germany (1)
- INR rebound (1)
- In vitro models (1)
- Metastatic breast cancer (1)
- PBM (1)
- PCDHGC3 (1)
- Patient Blood Management (PBM) (1)
- Pearson correlation coefficient (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- WNT signaling (1)
- Withings ScanWatch (1)
- acute Respiratory Distress Syndrome (1)
- acute kidney injury (1)
- adsorption (1)
- anaemia (1)
- anaemia walk‐in clinic (1)
- analgesics (1)
- anesthesia (1)
- anesthesiology (1)
- anesthetics (1)
- aneurysmal subarachnoid haemorrhage (1)
- animal model (1)
- anti-hormonal therapy (1)
- anticoagulant therapy (1)
- antiemetics (1)
- antimicrobial stewardship (1)
- anxiety (1)
- arteriovenous extracorporeal hemadsorption technique (1)
- artificial intelligence (1)
- astrocytoma (1)
- avoidable blood loss (1)
- bibliometrics (1)
- bioelectronics (1)
- bleeding (1)
- blood loss (1)
- blood purification (1)
- blood transfusion (1)
- brain (1)
- brain-metastasis (1)
- breast cancer metastases (1)
- cardioprotection (1)
- clinical decision support (1)
- clinical measurement in health technology (1)
- clinical studies (1)
- colorectal carcinoma (1)
- conference abstracts (1)
- coronavirus disease 2019 (1)
- critical illness (1)
- data display (1)
- death (1)
- depression (1)
- diagnostic blood loss (1)
- diagnostic correctness (1)
- digital phenotyping (1)
- dual-room trauma suite (1)
- ecological momentary assessment (1)
- emergency (1)
- emergency preparedness (1)
- endotoxin (1)
- enhanced recovery after surgery (1)
- epidural anaesthesia (1)
- epidural analgesia (1)
- evaluation (1)
- exercise (1)
- expression (1)
- extracellular vesicles (1)
- extracorporeal hemadsorption (1)
- extracorporeal membrane oxygenation (ECMO) (1)
- extracorporeal techniques in hemadsorption therapy (1)
- extravascular lung water (1)
- fish oil (1)
- fitness trackers (1)
- gene expression (1)
- general anesthesia (1)
- genetic polymorphisms (1)
- glioblastoma multiforme (1)
- glioma (1)
- growth differentiation factor 15 (1)
- haemoglobin concentration (1)
- haemostasis (1)
- health care (1)
- health sciences (1)
- health tracker (1)
- iatrogenic anemia (1)
- immune response (1)
- immunonutrition (1)
- immunosorbents (1)
- impedance aggregometry; WHOLE-BLOOD THROMBOELASTOMETRY; DEFINITION; DISEASE (1)
- in-bed cycling (1)
- inflammatory cytokines (1)
- intensive care (1)
- intensive care medicine (1)
- intensive care unit (1)
- internet of things (1)
- intracerebral haemorrhage (1)
- ischemia/reperfusion injury (1)
- laparoscopic surgery (1)
- left-ventricular assist device (1)
- lessons learned (1)
- longitudinal studies (1)
- mRNA (1)
- machine learning (1)
- major bleeding (1)
- mass casualties (1)
- maternal critical care (1)
- mechanical ventilation (1)
- mechanical ventilator weaning (1)
- medical devices (1)
- medical nutrition therapy (1)
- metastasis (1)
- microparticles (1)
- minimally invasive surgery (1)
- mobile crowdsensing (1)
- mobile health (1)
- molecular imaging (1)
- mortality (1)
- movable sliding gantry (1)
- multidisciplinary (1)
- multimodal treatments (1)
- network meta-analysis (1)
- neurological complications (1)
- neuropsychiatric disorders (1)
- nutrient supplementation (1)
- nutrition (1)
- obstetrics (1)
- omega-3 fatty acid (1)
- omega-6 fatty acid (1)
- oral nutrition supplements (1)
- orthopaedic patients (1)
- oxidative stress (1)
- oxygen/glucose deprivation (1)
- pandemia (1)
- parenteral nutrition (1)
- patient serum (1)
- personalized antimicrobial therapy (1)
- personalized medicine (1)
- pharmacokinetics (1)
- phenprocoumon (1)
- photoplethysmography (1)
- physical activity (1)
- piperacillin/tazobactam (1)
- point of care testing (1)
- point-of-care (1)
- point-of-care-testing (1)
- preconditioning (1)
- pregnancy (1)
- prehabilitation (1)
- preoperative anaemia management (1)
- prognostic marker (1)
- proliferation (1)
- protein (1)
- protocadherin gamma C3 (1)
- public health (1)
- public health preparedness (1)
- pulmonary edema (1)
- qualitative research (1)
- quality of life (1)
- recurrence (1)
- red blood cell transfusion (1)
- red blood cells (1)
- relapse (1)
- reticulocyte haemoglobin (1)
- risk prediction (1)
- robotic surgery (1)
- selective outcome reporting (1)
- selen (1)
- septic shock (1)
- situation awareness (1)
- situational awareness (1)
- smartwatch (1)
- solnatide (1)
- stress (1)
- stress resilience (1)
- supine hypotensive syndrome (1)
- systematic review (1)
- systematic review, (1)
- systemic reviews (1)
- technology (1)
- terror attacks (1)
- therapeutic drug monitoring (1)
- thromboelastometry (1)
- thrombosis (1)
- tight junctions (1)
- transfusion (1)
- transporter (1)
- traumatic brain injury (1)
- trial protocol (1)
- trial registration (1)
- tumor necrosis factor-α (1)
- urgent surgery (1)
- user-centred design (1)
- viral load (1)
- virtual reality (1)
- vitamin D (1)
- volatile anesthetics (1)
- volume clamp (1)
- vomiting (1)
- wearable (1)
- zinc (1)
Institute
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (49)
- Medizinische Klinik und Poliklinik I (6)
- Frauenklinik und Poliklinik (5)
- Institut für Klinische Epidemiologie und Biometrie (5)
- Neurochirurgische Klinik und Poliklinik (3)
- Institut für Hygiene und Mikrobiologie (2)
- Institut für Informatik (2)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (2)
- Medizinische Klinik und Poliklinik II (2)
Sonstige beteiligte Institutionen
Objective
In this abridged version of the recently published Cochrane review on antiemetic drugs, we summarize its most important findings and discuss the challenges and the time needed to prepare what is now the largest Cochrane review with network meta-analysis in terms of the number of included studies and pages in its full printed form.
Methods
We conducted a systematic review with network meta-analyses to compare and rank single antiemetic drugs and their combinations belonging to 5HT₃-, D₂-, NK₁-receptor antagonists, corticosteroids, antihistamines, and anticholinergics used to prevent postoperative nausea and vomiting in adults after general anesthesia.
Results
585 studies (97 516 participants) testing 44 single drugs and 51 drug combinations were included. The studies’ overall risk of bias was assessed as low in only 27% of the studies. In 282 studies, 29 out of 36 drug combinations and 10 out of 28 single drugs lowered the risk of vomiting at least 20% compared to placebo. In the ranking of treatments, combinations of drugs were generally more effective than single drugs. Single NK1 receptor antagonists were as effective as other drug combinations. Of the 10 effective single drugs, certainty of evidence was high for aprepitant, ramosetron, granisetron, dexamethasone, and ondansetron, while moderate for fosaprepitant and droperidol. For serious adverse events (SAEs), any adverse event (AE), and drug-class specific side effects evidence for intervention effects was mostly not convincing.
Conclusions
There is high or moderate evidence for at least seven single drugs preventing postoperative vomiting. However, there is still considerable lack of evidence regarding safety aspects that does warrant investigation.
Advances in breast cancer management and extracellular vesicle research, a bibliometric analysis
(2021)
Extracellular vesicles transport variable content and have crucial functions in cell–cell communication. The role of extracellular vesicles in cancer is a current hot topic, and no bibliometric study has ever analyzed research production regarding their role in breast cancer and indicated the trends in the field. In this way, we aimed to investigate the trends in breast cancer management involved with extracellular vesicle research. Articles were retrieved from Scopus, including all the documents published concerning breast cancer and extracellular vesicles. We analyzed authors, journals, citations, affiliations, and keywords, besides other bibliometric analyses, using R Studio version 3.6.2. and VOSviewer version 1.6.0. A total of 1151 articles were retrieved, and as the main result, our analysis revealed trending topics on biomarkers of liquid biopsy, drug delivery, chemotherapy, autophagy, and microRNA. Additionally, research related to extracellular vesicles in breast cancer has been focused on diagnosis, treatment, and mechanisms of action of breast tumor-derived vesicles. Future studies are expected to explore the role of extracellular vesicles on autophagy and microRNA, besides investigating the application of extracellular vesicles from liquid biopsies for biomarkers and drug delivery, enabling the development and validation of therapeutic strategies for specific cancers.
The blood-brain barrier (BBB) is a highly specialized structure that separates the brain from the blood and allows the exchange of molecules between these two compartments through selective channels. The breakdown of the BBB is implicated in the development of severe neurological diseases, especially stroke and traumatic brain injury. Oxygen-glucose deprivation is used to mimic stroke and traumatic brain injury in vitro. Pathways that trigger BBB dysfunction include an imbalance of oxidative stress, excitotoxicity, iron metabolism, cytokine release, cell injury, and cell death. MicroRNAs are small non-coding RNA molecules that regulate gene expression and are emerging as biomarkers for the diagnosis of central nervous system (CNS) injuries. In this review, the regulatory role of potential microRNA biomarkers and related therapeutic targets on the BBB is discussed. A thorough understanding of the potential role of various cellular and linker proteins, among others, in the BBB will open further therapeutic options for the treatment of neurological diseases.
(1) Background: Data on coronavirus 2 infection during pregnancy vary. We aimed to describe maternal characteristics and clinical presentation of SARS-CoV-2 positive women requiring intensive care treatment for COVID-19 during pregnancy and postpartum period based on data of a comprehensive German surveillance system in obstetric patients. (2) Methods: Data from COVID-19 Related Obstetric and Neonatal Outcome Study (CRONOS), a prospective multicenter registry for SARS-CoV-2 positive pregnant women, was analyzed with respect to ICU treatment. All women requiring intensive care treatment for COVID-19 were included and compared regarding maternal characteristics, course of disease, as well as maternal and neonatal outcomes. (3) Results: Of 2650 cases in CRONOS, 101 women (4%) had a documented ICU stay. Median maternal age was 33 (IQR, 30–36) years. COVID-19 was diagnosed at a median gestational age of 33 (IQR, 28–35) weeks. As the most invasive form of COVID-19 treatment interventions, patients received either continuous monitoring of vital signs without further treatment requirement (n = 6), insufflation of oxygen (n = 30), non-invasive ventilation (n = 22), invasive ventilation (n = 28), or escalation to extracorporeal membrane oxygenation (n = 15). No significant clinical differences were identified between patients receiving different forms of ventilatory support for COVID-19. Prevalence of preterm delivery was significantly higher in women receiving invasive respiratory treatments. Four women died of COVID-19 and six fetuses were stillborn. (4) Conclusions: Our cohort shows that progression of COVID-19 is rare in pregnant and postpartum women treated in the ICU. Preterm birth rate is high and COVID-19 requiring respiratory support increases the risk of poor maternal and neonatal outcome.
Visual Blood, a 3D animated computer model to optimize the interpretation of blood gas analysis
(2023)
Acid–base homeostasis is crucial for all physiological processes in the body and is evaluated using arterial blood gas (ABG) analysis. Screens or printouts of ABG results require the interpretation of many textual elements and numbers, which may delay intuitive comprehension. To optimise the presentation of the results for the specific strengths of human perception, we developed Visual Blood, an animated virtual model of ABG results. In this study, we compared its performance with a conventional result printout. Seventy physicians from three European university hospitals participated in a computer-based simulation study. Initially, after an educational video, we tested the participants’ ability to assign individual Visual Blood visualisations to their corresponding ABG parameters. As the primary outcome, we tested caregivers’ ability to correctly diagnose simulated clinical ABG scenarios with Visual Blood or conventional ABG printouts. For user feedback, participants rated their agreement with statements at the end of the study. Physicians correctly assigned 90% of the individual Visual Blood visualisations. Regarding the primary outcome, the participants made the correct diagnosis 86% of the time when using Visual Blood, compared to 68% when using the conventional ABG printout. A mixed logistic regression model showed an odds ratio for correct diagnosis of 3.4 (95%CI 2.00–5.79, p < 0.001) and an odds ratio for perceived diagnostic confidence of 1.88 (95%CI 1.67–2.11, p < 0.001) in favour of Visual Blood. A linear mixed model showed a coefficient for perceived workload of −3.2 (95%CI −3.77 to −2.64) in favour of Visual Blood. Fifty-one of seventy (73%) participants agreed or strongly agreed that Visual Blood was easy to use, and fifty-five of seventy (79%) agreed that it was fun to use. In conclusion, Visual Blood improved physicians’ ability to diagnose ABG results. It also increased perceived diagnostic confidence and reduced perceived workload. This study adds to the growing body of research showing that decision-support tools developed around human cognitive abilities can streamline caregivers’ decision-making and may improve patient care.
Therapeutic drug monitoring (TDM) is increasingly relevant for an individualized antibiotic therapy and subsequently a necessary tool to reduce multidrug-resistant pathogens, especially in light of diminishing antimicrobial capabilities. Critical illness is associated with profound pharmacokinetic and pharmacodynamic alterations, which challenge dose finding and the application of particularly hydrophilic drugs such as β-lactam antibiotics. Methods: Implementation strategy, potential benefit, and practicability of the developed standard operating procedures were retrospectively analyzed from January to December 2020. Furthermore, the efficacy of the proposed dosing target of piperacillin in critically ill patients was evaluated. Results: In total, 160 patients received piperacillin/tazobactam therapy and were subsequently included in the study. Of them, 114 patients received piperacillin/tazobactam by continuous infusion and had at least one measurement of piperacillin serum level according to the standard operating procedure. In total, 271 measurements were performed with an average level of 79.0 ± 46.0 mg/L. Seventy-one piperacillin levels exceeded 100 mg/L and six levels were lower than 22.5 mg/L. The high-level and the low-level group differed significantly in infection laboratory parameters (CRP (mg/dL) 20.18 ± 11.71 vs. 5.75 ± 5.33) and renal function [glomerular filtration rate (mL/min/1.75 m2) 40.85 ± 26.74 vs. 120.50 ± 70.48]. Conclusions: Piperacillin levels are unpredictable in critically ill patients. TDM during piperacillin/tazobactam therapy is highly recommended for all patients. Although our implementation strategy was effective, further strategies implemented into the daily clinical workflow might support the health care staff and increase the clinicians' alertness.
PURPOSE
The threat of national and international terrorism remains high. Preparation is the key requirement for the resilience of hospitals and out-of-hospital rescue forces. The scientific evidence for defining medical and tactical strategies often feeds on the analysis of real incidents and the lessons learned derived from them. This systematic review of the literature aims to identify and systematically report lessons learned from terrorist attacks since 2001.
METHODS
PubMed was used as a database using predefined search strategies and eligibility criteria. All countries that are part of the Organization for Economic Cooperation and Development (OECD) were included. The time frame was set between 2001 and 2018.
RESULTS
Finally 68 articles were included in the review. From these, 616 lessons learned were extracted and summarized into 15 categories. The data shows that despite the difference in attacks, countries, and casualties involved, many of the lessons learned are similar. We also found that the pattern of lessons learned is repeated continuously over the time period studied.
CONCLUSIONS
The lessons from terrorist attacks since 2001 follow a certain pattern and remained constant over time. Therefore, it seems to be more accurate to talk about lessons identified rather than lessons learned. To save as many victims as possible, protect rescue forces from harm, and to prepare hospitals at the best possible level it is important to implement the lessons identified in training and preparation.
Purpose
Anaemia is common in patients presenting with aneurysmal subarachnoid (aSAH) and intracerebral haemorrhage (ICH). In surgical patients, anaemia was identified as an idenpendent risk factor for postoperative mortality, prolonged hospital length of stay (LOS) and increased risk of red blood cell (RBC) transfusion. This multicentre cohort observation study describes the incidence and effects of preoperative anaemia in this critical patient collective for a 10-year period.
Methods
This multicentre observational study included adult in-hospital surgical patients diagnosed with aSAH or ICH of 21 German hospitals (discharged from 1 January 2010 to 30 September 2020). Descriptive, univariate and multivariate analyses were performed to investigate the incidence and association of preoperative anaemia with RBC transfusion, in-hospital mortality and postoperative complications in patients with aSAH and ICH.
Results
A total of n = 9081 patients were analysed (aSAH n = 5008; ICH n = 4073). Preoperative anaemia was present at 28.3% in aSAH and 40.9% in ICH. RBC transfusion rates were 29.9% in aSAH and 29.3% in ICH. Multivariate analysis revealed that preoperative anaemia is associated with a higher risk for RBC transfusion (OR = 3.25 in aSAH, OR = 4.16 in ICH, p < 0.001), for in-hospital mortality (OR = 1.48 in aSAH, OR = 1.53 in ICH, p < 0.001) and for several postoperative complications.
Conclusions
Preoperative anaemia is associated with increased RBC transfusion rates, in-hospital mortality and postoperative complications in patients with aSAH and ICH.
Background
Acute respiratory distress syndrome (ARDS) is a complex clinical diagnosis with various possible etiologies. One common feature, however, is pulmonary permeability edema, which leads to an increased alveolar diffusion pathway and, subsequently, impaired oxygenation and decarboxylation. A novel inhaled peptide agent (AP301, solnatide) was shown to markedly reduce pulmonary edema in animal models of ARDS and to be safe to administer to healthy humans in a Phase I clinical trial. Here, we present the protocol for a Phase IIB clinical trial investigating the safety and possible future efficacy endpoints in ARDS patients.
Methods
This is a randomized, placebo-controlled, double-blind intervention study. Patients with moderate to severe ARDS in need of mechanical ventilation will be randomized to parallel groups receiving escalating doses of solnatide or placebo, respectively. Before advancing to a higher dose, a data safety monitoring board will investigate the data from previous patients for any indication of patient safety violations. The intervention (application of the investigational drug) takes places twice daily over the course of 7 days, ensued by a follow-up period of another 21 days.
Discussion
The patients to be included in this trial will be severely sick and in need of mechanical ventilation. The amount of data to be collected upon screening and during the course of the intervention phase is substantial and the potential timeframe for inclusion of any given patient is short. However, when prepared properly, adherence to this protocol will make for the acquisition of reliable data. Particular diligence needs to be exercised with respect to informed consent, because eligible patients will most likely be comatose and/or deeply sedated at the time of inclusion.
Trial registration
This trial was prospectively registered with the EU Clinical trials register (clinicaltrialsregister.eu). EudraCT Number: 2017-003855-47.
Background
The viral load and tissue distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain important questions. The current study investigated SARS-CoV-2 viral load, biodistribution and anti-SARS-CoV-2 antibody formation in patients suffering from severe corona virus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS).
Methods
This is a retrospective single-center study in 23 patients with COVID-19-induced ARDS. Data were collected within routine intensive care. SARS-CoV-2 viral load was assessed via reverse transcription quantitative polymerase chain reaction (RT-qPCR). Overall, 478 virology samples were taken. Anti-SARS-CoV-2-Spike-receptor binding domain (RBD) antibody detection of blood samples was performed with an enzyme-linked immunosorbent assay.
Results
Most patients (91%) suffered from severe ARDS during ICU treatment with a 30-day mortality of 30%. None of the patients received antiviral treatment. Tracheal aspirates tested positive for SARS-CoV-2 in 100% of the cases, oropharyngeal swabs only in 77%. Blood samples were positive in 26% of the patients. No difference of viral load was found in tracheal or blood samples with regard to 30-day survival or disease severity. SARS-CoV-2 was never found in dialysate. Serologic testing revealed significantly lower concentrations of SARS-CoV-2 neutralizing IgM and IgA antibodies in survivors compared to non-survivors (p = 0.009).
Conclusions
COVID-19 induced ARDS is accompanied by a high viral load of SARS-CoV-2 in tracheal aspirates, which remained detectable in the majority throughout intensive care treatment. Remarkably, SARS-CoV-2 RNA was never detected in dialysate even in patients with RNAemia. Viral load or the buildup of neutralizing antibodies was not associated with 30-day survival or disease severity.